SIBIONICS GS1

Regulatory Information:
The SIBIONICS GS1 Continuous Glucose Monitoring (CGM) system is a CE-marked medical device (CE Mark issued under EU MDR).
This app is only intended for use with SIBIONICS GS1 CGM sensors, which are legally available in the following countries and regions only:
Europe
Albania, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, North Macedonia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Ireland, Iceland, France, Finland, Greece, Hungary, Italy, Kosovo, Latvia, Lithuania, Luxembourg, Malta, Montenegro, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Sweden, Switzerland, Türkiye, Ukraine, United Kingdom
Asia
Afghanistan, Azerbaijan, Bahrain, Brunei, Hong Kong SAR, Indonesia, Iraq, Israel, Jordan, Kazakhstan, Kuwait, Macao SAR, Malaysia, Maldives, Mongolia, Oman, Pakistan, Qatar, Saudi Arabia, Singapore, South Korea, Sri Lanka, Tajikistan, Turkmenistan, United Arab Emirates, Uzbekistan, Vietnam
Africa
Algeria, Angola, Botswana, Côte d’Ivoire, Egypt, Ghana, Kenya, Libya, Madagascar, Mauritius, Morocco, Nigeria, Senegal, Seychelles, South Africa, Tunisia
North America & Caribbean
Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Panama, Trinidad and Tobago
South America
Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay, Venezuela
This app and device are NOT FDA-cleared and are not intended for sale or use in the United States or in any other country or region not listed above.
Disclaimer: Always consult your healthcare provider before making any treatment decisions. Do not use this app as a substitute for professional medical advice.